Money Control Place
  • Politics
  • Business
  • Stocks
  • Investing
  • Politics
  • Business
  • Stocks
  • Investing

Money Control Place

Investing

First patient dosed in Phase IIb imaging for Brain Mets

by admin April 28, 2025
April 28, 2025
First patient dosed in Phase IIb imaging for Brain Mets

Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets

Download the PDF here.

This post appeared first on investingnews.com

0
FacebookTwitterGoogle +Pinterest
previous post
Binding Commitments Received for A$1.0 Million under Convertible Note Placement
next post
S&P 500 Rises from Bearish to Neutral, But Will It Last?

Related Posts

Canadian Investment Regulatory Organization Trade Resumption – STS

May 7, 2024

NorthStar Gaming to Host Q4 and Year-End 2024...

April 17, 2025

Group Eleven Drills Best Hole Yet at Ballywire:...

July 2, 2025

CHARBONE Announces the Official Start of Civil Construction...

October 28, 2025

RCM to Acquire Webbs Consol Silver Project from...

September 1, 2025

Can You Invest in Neuralink?

February 1, 2025

Tuttle Capital Files for ETF Tied to UFO-Related...

February 19, 2025

Joe Cavatoni: Gold Shining, Risk Assets Under Pressure...

March 28, 2025

5 Top Weekly TSX Stocks: Oil and Gas...

September 4, 2023

New Purpose ETFs Give Canadian Investors Access to...

February 21, 2025

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest

    • S&P 500 Breaking Out Again: What This Means for Your Portfolio

    • S&P 500 Breaking Out Again: What This Means for Your Portfolio

    • S&P 500 Breaking Out Again: What This Means for Your Portfolio

    • Biotech Market Forecast: Top Trends for Biotech in 2026

    • What is the Santa Claus Rally and Has it Arrived?

    • Craig Hemke: Silver, Gold’s “Outstanding” Year — Will 2026 Bring a Repeat?

    Categories

    • Business (1,424)
    • Investing (3,316)
    • Politics (3,699)
    • Stocks (1,893)
    • Uncategorized (20)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: MoneyControlPlace.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 moneycontrolplace.com | All Rights Reserved